Abstract: A visual stimulus for a set of contrast cards is provided which comprises a hollow outer circle, opposing and identical first and second arc segment within the outer circle which are symmetrical about the vertical diameter of the outer circle, a first filled-in circle and a second filled-in circle being identical in diameter to the first filled-in circle, each residing on opposite ends of the horizontal diameter of the outer circle and each being equidistant from the center of the outer circle, a filled-in center element having a rotational center on the center of the outer circle, the center element being symmetrical about both the horizontal and vertical diameter of the outer circle.

Abstract: A visual stimulus for a set of contrast cards is provided which comprises a hollow outer circle, opposing and identical first and second arc segment within the outer circle which are symmetrical about the vertical diameter of the outer circle, a first filled-in circle and a second filled-in circle being identical in diameter to the first filled-in circle, each residing on opposite ends of the horizontal diameter of the outer circle and each being equidistant from the center of the outer circle, a filled-in center element having a rotational center on the center of the outer circle, the center element being symmetrical about both the horizontal and vertical diameter of the outer circle.

Abstract: A myopia-inhibiting treatment device produces a therapeutic light that includes components of different wavelengths in a ratio of luminosities that creates a predetermined L-cone to S-cone excitation profile that slows ocular growth, thereby mitigating development of myopia. The components comprise blue light, green light, and red light. Therapeutic light may cause an L-cone to S-cone excitation ratio in a range between 1.38 and 0.05. In some implementations the therapeutic light causes a L-cone to S-cone excitation ratio of 0.74. In some implementations the luminosity of the combined light components is greater than 700 lux.

Abstract: A myopia-inhibiting treatment device produces a therapeutic light that includes components of different wavelengths in a ratio of luminosities that creates a predetermined L-cone to S-cone excitation profile that slows ocular growth, thereby mitigating development of myopia. The components comprise blue light, green light, and red light. Therapeutic light may cause an L-cone to S-cone excitation ratio in a range between 1.38 and 0.05. In some implementations the therapeutic light causes a L-cone to S-cone excitation ratio of 0.74. In some implementations the luminosity of the combined light components is greater than 700 lux.

Abstract: A method and apparatus for reducing or preventing myopia is presented. In one mode, a display includes a front surface and a region is provided along at least one area of the front surface. The region provides temporal stimulation to a user viewing the display, which results in the prevention or reduction of myopia in a person viewing the display without the need for accurate accommodation or binocular fixation. In a second mode, a stand-alone device provides temporal stimulation to a user viewing the display, which results in the prevention or reduction of myopia in a person viewing the display. In a third mode, the temporal stimulation is projected into the viewer's field of view, which results in the prevention or reduction of myopia in a person viewing the projection.

Abstract: A method for at least one of preventing myopia and retarding the progression of myopia is provided. The method includes measuring optical aberrations in a human eye (42, 43, 44) and correcting the optical aberrations (46). Measuring optical aberrations (42, 43, 44) may include measuring wavefront aberrations (45) of parallel light rays entering the eye.

Abstract: A method for at least one of preventing myopia and retarding the progression of myopia is provided. The method includes measuring optical aberrations in a human eye and correcting the optical aberrations. Measuring optical aberrations may include measuring wavefront aberrations of parallel light rays entering the eye.